The Ultimate Combination of an Effortless User Experience with Medical Grade Clinical Accuracy for Scalable Remote Care

Accelerate your RPM and Virtual Care programs with a comprehensive solution approach and offering adopted by hospitals/health systems, provider organizations and payors in the U.S. and select markets globally.

• An effortless user experience for passive, high-frequency vital sign collection with the rechargeable BioButton multi-patient and single-use wearables for in-hospital and at-home monitoring
• Medical grade data capture and insights with clinical accuracy physicians can trust
• Data analytics and services to enable early detection of adverse vital sign trends
• Cost-effective continuous physiologic monitoring with the award-winning BioButton single-use and multi-patient use wearable medical devices

Our Founders

James Mault, MD, FACS
Founder + CEO

Dr. Mault has more than 35 years of experience in senior executive positions in the health IT and medical device industry as well as clinical medicine. He has founded five health IT and medical device companies, leading these companies to develop novel devices and software technologies, gain FDA approvals and forge strategic partnerships with numerous Fortune 500 companies. He is the named inventor of over 80 issued and pending patents for a variety of health IT and medical device innovations. Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. He has been board-certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care.

David Wang
Co-Founder + CTO

Dave brings 20 years of experience in product execution and innovation. As the founding CEO of Striiv Corp, he spearheaded all aspects of building and executing seven generations of biometric wearables, shipping millions of devices to customers including United Healthcare, Pfizer, Walgreens, Acer, Best Buy and Qualcomm Life. Dave’s expertise is in building teams while simultaneously building products that combine multiple technology disciplines. Dave graduated from Stanford University with a dual M.S. degree in Electrical Engineering and Management Science and Engineering, and he received a B.S. in Electrical Engineering and Computer Science from UC Berkeley. He also holds over 15 patents in the fields of sensors, algorithms, edge processing and validation.

Executive Leadership Team

Brett Atwood
Chief Development
Officer

Josh Miller
Chief Operating
Officer

Carolyn Walsh
Chief Commercial
Officer

Join Team BioIntelliSense

News + Insights

Learn more about how BioIntelliSense can scale your remote patient monitoring programs.

BioIntelliSense partners with Hicuity Health to offer scalable end-to-end continuous patient monitoring Learn more ›

Peer-reviewed BioButton^® Study Demonstrates Clinical Impact on Hospitalized Patients Learn more ›

BioIntelliSense announces FDA clearance of the BioButton^® Multi-Patient wearable and BioDashboard^™ system Learn more ›

iRhythm Technologies enters License Agreement with BioIntelliSense for Ambulatory Cardiac Monitoring Learn more ›

BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton^® Continuous Patient Monitoring Solution Learn more ›

BioIntelliSense and UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients Learn more ›

New Published Research from OptumCare: Enhancing Oncology Side Effect Management Using a Remote Patient Monitoring System Learn more ›

BioIntelliSense Named “2023 Best Overall Medical Device Company” in 7th Annual MedTech Breakthrough Awards Program Learn more ›

Amplifire and BioIntelliSense Partner to Accelerate Continuous Care with Science-based, Adaptive Clinical Training Learn more ›

BioIntelliSense and care.ai Announce Partnership to Leverage Continuous Biometric Data and Ambient Intelligent Monitoring to Improve the Delivery of Patient Care Learn more ›

BioIntelliSense named CES 2023 Innovation Award Honoree for its BioButton^® continuous monitoring and clinical intelligence solutions for in-hospital to home Learn more ›

Ardent Health Services and BioIntelliSense Launch State-of-the-Art Continuous Inpatient Monitoring Initiative to Advance Care and Optimize Workflow Learn more ›

BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space Learn more ›

BioIntelliSense and Medically Home Announce Strategic Collaboration to Enhance Patient Management for High Acuity Hospital Care at Home Learn more ›

BioIntelliSense Launches Patented, FDA-cleared Pulse Oximetry (SpO2) Sensor Technology that Addresses Skin Pigmentation and Motion Monitoring Challenges Learn more ›

BioIntelliSense acquires AlertWatch^® clinical Intelligence engine to expand its continuous patient monitoring portfolio Learn more ›

BioIntelliSense and Medtronic Form Strategic U.S. Hospital Channel Partnership for Continuous Remote Patient Monitoring From In-Hospital to Home Learn more ›

UC Davis Health and BioIntelliSense Form Strategic Collaboration to Advance Continuous Remote Care Models for In-Hospital to Home Monitoring Learn more ›

Houston Methodist and BioIntelliSense Announce Strategic Collaboration to Advance New Remote Care and Clinical Intelligence Solutions Learn more ›

Anelto and BioIntelliSense Partner to Provide Remote Patient Monitoring for Seniors Learn more ›

Introducing the BioButton Rechargeable medical grade wearable device and data services Learn more ›

BioIntelliSense and UAE-based Mubadala Health Establish Strategic Collaboration to Enable Continuous Care Model Learn more ›

BioIntelliSense and Renown Strategic Collaboration for Scalable Continuous Care Learn more ›

Joerns Healthcare and BioIntelliSense Announce North American Partnership Learn more ›

CareAngel integrates with BioIntelliSense to extend care for at-risk patient populations Learn more ›

Myia Health and BioIntelliSense Partner to Integrate Continuous Vital Sign Monitoring Into the Myia Platform Learn more ›

BioIntelliSense Honored by Goldman Sachs for Entrepreneurship Learn more ›

BioIntelliSense BioButton™ Named Best New Monitoring Solution by MedTech Breakthrough Awards Learn more ›

ClearDATA and BioIntelliSense Combine Capabilities to Enhance Remote Patient Monitoring Platform Security and Compliance Learn more ›

Aloe Care Health Partners with Biointellisense to Integrate Groundbreaking Continuous Vital Sign Monitoring Learn more ›

BioIntelliSense and LLS Form Strategic Collaboration to Advance Oncology Care and Clinical Research Learn more ›

BioIntelliSense and ACC Join Forces Learn more ›

COVID-19 Vaccination Monitoring at UCHealth Learn more ›

BioButton Named CES 2021 Best of Innovation Award Honoree Learn more ›

Featuring Dr. Mault on Bloomberg Live (11.25.2020) Learn more ›

Philips and BioIntelliSense form strategic collaboration Learn more ›

Introducing the 5G-enabled BioHub Watch video ›

Introducing the 5G-enabled BioHub gateway to the RPM Data Service Learn more ›

First-of-its-Kind Medical Grade Symptomatic and Multi-Parameter Biometric Monitoring Learn more ›

The Revolutionary BioSticker Receives FDA 510(k) Clearance Learn more ›

BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform Learn more ›